Saturated fat and Type 2 diabetes: where do we stand?
Dietary treatment of Type 2 diabetes has long been open to controversy and debate, and this is especially true of the relationship between saturated fat (SFA) and cardiovascular disease (CVD). Over the past couple of years, various studies [1–3] have resulted in headlines claiming that experts have...
Autore principale: | Dyson, P |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Wiley
2016
|
Documenti analoghi
Documenti analoghi
-
Foot practices in patients with type 2 diabetes: Where do we stand?
di: Tehseen Fatima, et al.
Pubblicazione: (2020-01-01) -
Where do we stand on human diabetic nephropathy?
di: Dae Ryong Cha
Pubblicazione: (2013-09-01) -
Diabetes Care in Iran: Where We Stand and Where We Are Headed
di: Sina Noshad, et al.
Pubblicazione: (2016-04-01) -
Diabetic kidney disease, revisited: where do we stand?
di: Dae Ryong Cha
Pubblicazione: (2022-09-01) -
Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
di: P. Reddi Rani, et al.
Pubblicazione: (2016-04-01)